Annual Cash & Cash Equivalents
$34.02 M
-$16.59 M-32.79%
December 1, 2023
Summary
- As of February 6, 2025, CSCI annual cash & cash equivalents is $34.02 million, with the most recent change of -$16.59 million (-32.79%) on December 1, 2023.
- During the last 3 years, CSCI annual cash & cash equivalents has risen by +$9.74 million (+40.15%).
- CSCI annual cash & cash equivalents is now -47.91% below its all-time high of $65.30 million, reached on December 1, 2021.
Performance
CSCI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$20.00 M
-$7.81 M-28.08%
September 1, 2024
Summary
- As of February 6, 2025, CSCI quarterly cash and cash equivalents is $20.00 million, with the most recent change of -$7.81 million (-28.08%) on September 1, 2024.
- Over the past year, CSCI quarterly cash and cash equivalents has increased by +$13.33 million (+199.98%).
- CSCI quarterly cash and cash equivalents is now -28.08% below its all-time high of $27.80 million, reached on June 1, 2024.
Performance
CSCI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CSCI Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.8% | +200.0% |
| 3 y3 years | +40.1% | +200.0% |
| 5 y5 years | +134.4% | +200.0% |
CSCI Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.9% | at low | -28.1% | +469.2% |
| 5 y | 5-year | -47.9% | +334.0% | -28.1% | +1306.5% |
| alltime | all time | -47.9% | +717.6% | -28.1% | >+9999.0% |
COSCIENS Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $20.00 M(-28.1%) |
| Jun 2024 | - | $27.80 M(+691.4%) |
| Mar 2024 | - | $3.51 M(-47.3%) |
| Dec 2023 | $34.02 M(-32.8%) | $6.67 M(-20.2%) |
| Sep 2023 | - | $8.35 M(-2.1%) |
| Jun 2023 | - | $8.53 M(-8.1%) |
| Mar 2023 | - | $9.29 M(-8.7%) |
| Dec 2022 | $50.61 M(-22.5%) | $10.18 M(+7.8%) |
| Sep 2022 | - | $9.44 M(+7.0%) |
| Jun 2022 | - | $8.82 M(+25.4%) |
| Mar 2022 | - | $7.03 M(+15.3%) |
| Dec 2021 | $65.30 M(+169.0%) | $6.10 M(+5.0%) |
| Sep 2021 | - | $5.81 M(-0.9%) |
| Jun 2021 | - | $5.86 M(+41.3%) |
| Mar 2021 | - | $4.15 M(-1.4%) |
| Dec 2020 | $24.27 M(+209.7%) | $4.21 M(-7.9%) |
| Sep 2020 | - | $4.57 M(+46.3%) |
| Jun 2020 | - | $3.12 M(+96.5%) |
| Mar 2020 | - | $1.59 M(+11.8%) |
| Dec 2019 | $7.84 M(-46.0%) | $1.42 M(-27.5%) |
| Sep 2019 | - | $1.96 M(+14.5%) |
| Jun 2019 | - | $1.71 M(+20.4%) |
| Mar 2019 | - | $1.42 M(+5.1%) |
| Dec 2018 | $14.51 M(+86.5%) | $1.35 M(-57.9%) |
| Sep 2018 | - | $3.22 M(-21.7%) |
| Jun 2018 | - | $4.11 M(-11.3%) |
| Mar 2018 | - | $4.64 M(-5.6%) |
| Dec 2017 | $7.78 M(-64.6%) | $4.91 M(-18.1%) |
| Sep 2017 | - | $5.99 M(+10.1%) |
| Jun 2017 | - | $5.44 M(-7.3%) |
| Mar 2017 | - | $5.87 M(-13.8%) |
| Dec 2016 | $22.00 M(-46.9%) | $6.81 M(-3.2%) |
| Sep 2016 | - | $7.03 M(+899.9%) |
| Jun 2016 | - | $703.30 K(-54.3%) |
| Mar 2016 | - | $1.54 M(+27.1%) |
| Dec 2015 | $41.45 M(+18.7%) | $1.21 M(+100.5%) |
| Sep 2015 | - | $604.20 K(+36.3%) |
| Jun 2015 | - | $443.20 K(+4.4%) |
| Mar 2015 | - | $424.70 K(+80.7%) |
| Dec 2014 | $34.93 M(-19.1%) | $235.00 K(-32.9%) |
| Sep 2014 | - | $350.00 K(-47.3%) |
| Jun 2014 | - | $664.10 K(-39.5%) |
| Mar 2014 | - | $1.10 M(-40.2%) |
| Dec 2013 | $43.20 M(+9.3%) | $1.83 M(+370.1%) |
| Sep 2013 | - | $390.20 K(+14.6%) |
| Jun 2013 | - | $340.60 K(+37.0%) |
| Mar 2013 | - | $248.60 K(-9.4%) |
| Dec 2012 | $39.52 M(-15.7%) | $274.50 K(-48.4%) |
| Sep 2012 | - | $532.10 K(+60.1%) |
| Jun 2012 | - | $332.30 K(-34.9%) |
| Mar 2012 | - | $510.40 K(-12.0%) |
| Dec 2011 | $46.88 M | $580.10 K(+12.5%) |
| Sep 2011 | - | $515.70 K(+6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | - | $483.80 K(-5.8%) |
| Mar 2011 | - | $513.70 K(+175.1%) |
| Dec 2010 | $32.00 M(-16.0%) | $186.70 K(-14.2%) |
| Sep 2010 | - | $217.70 K(+743.8%) |
| Jun 2010 | - | $25.80 K(-69.9%) |
| Mar 2010 | - | $85.70 K(-22.3%) |
| Dec 2009 | $38.10 M(-22.6%) | $110.30 K(+723.1%) |
| Sep 2009 | - | $13.40 K(-87.3%) |
| Jun 2009 | - | $105.60 K(+1660.0%) |
| Mar 2009 | - | $6000.00(-55.9%) |
| Dec 2008 | $49.23 M(+379.2%) | $13.60 K(-90.4%) |
| Sep 2008 | - | $141.10 K(+255.4%) |
| Jun 2008 | - | $39.70 K(-89.7%) |
| Mar 2008 | - | $387.10 K(-70.1%) |
| Dec 2007 | $10.27 M(+9.8%) | $1.29 M(-25.6%) |
| Sep 2007 | - | $1.74 M(-25.7%) |
| Jun 2007 | - | $2.34 M(+1397.5%) |
| Mar 2007 | - | $156.50 K(-41.3%) |
| Dec 2006 | $9.36 M(-24.4%) | $266.80 K(-28.0%) |
| Sep 2006 | - | $370.70 K(-56.7%) |
| Jun 2006 | - | $855.70 K(+31.6%) |
| Mar 2006 | - | $650.40 K(+72.4%) |
| Dec 2005 | $12.38 M(-47.8%) | $377.20 K(+268.4%) |
| Sep 2005 | - | $102.40 K(+13.7%) |
| Jun 2005 | - | $90.10 K(-21.0%) |
| Mar 2005 | - | $114.10 K(+42.4%) |
| Dec 2004 | $23.74 M(+37.3%) | $80.10 K(-2.4%) |
| Sep 2004 | - | $82.10 K(-21.3%) |
| Jun 2004 | - | $104.30 K(-25.3%) |
| Mar 2004 | - | $139.70 K(-27.1%) |
| Dec 2003 | $17.28 M(+117.8%) | $191.60 K(+21.0%) |
| Sep 2003 | - | $158.30 K(+122.6%) |
| Jun 2003 | - | $71.10 K(+552.3%) |
| Mar 2003 | - | $10.90 K(-32.3%) |
| Dec 2002 | $7.94 M(+5.3%) | $16.10 K(-62.6%) |
| Sep 2002 | - | $43.00 K(+1031.6%) |
| Jun 2002 | - | $3800.00(-60.8%) |
| Mar 2002 | - | $9700.00(-69.6%) |
| Dec 2001 | $7.53 M(+55.6%) | $31.90 K(+22.2%) |
| Sep 2001 | - | $26.10 K(+31.2%) |
| Jun 2001 | - | $19.90 K(-46.9%) |
| Mar 2001 | - | $37.50 K(+49.4%) |
| Dec 2000 | $4.84 M(+16.4%) | $25.10 K(+55.9%) |
| Sep 2000 | - | $16.10 K(-76.1%) |
| Jun 2000 | - | $67.50 K(-1.9%) |
| Mar 2000 | - | $68.80 K(+1.0%) |
| Dec 1999 | $4.16 M(-79.9%) | - |
| Sep 1999 | - | $68.10 K(-48.0%) |
| Dec 1998 | $20.67 M(-26.1%) | - |
| Sep 1998 | - | $131.00 K(-9.6%) |
| Dec 1997 | $27.95 M(+14.7%) | - |
| Jun 1997 | - | $144.90 K(-90.0%) |
| Mar 1997 | - | $1.45 M |
| Dec 1996 | $24.37 M | - |
FAQ
- What is COSCIENS Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual cash & cash equivalents year-on-year change?
- What is COSCIENS Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly cash and cash equivalents year-on-year change?
What is COSCIENS Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of CSCI is $34.02 M
What is the all time high annual cash & cash equivalents for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual cash & cash equivalents is $65.30 M
What is COSCIENS Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, CSCI annual cash & cash equivalents has changed by -$16.59 M (-32.79%)
What is COSCIENS Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CSCI is $20.00 M
What is the all time high quarterly cash and cash equivalents for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly cash and cash equivalents is $27.80 M
What is COSCIENS Biopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, CSCI quarterly cash and cash equivalents has changed by +$13.33 M (+199.98%)